| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/03/2006 | EP1651642A1 Pna monomer and precursor |
| 05/03/2006 | EP1651641A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651640A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651631A1 Bicyclic imidazol derivatives against flaviviridae |
| 05/03/2006 | EP1651622A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 05/03/2006 | EP1651621A1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 05/03/2006 | EP1651620A2 Piperazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651612A1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/03/2006 | EP1651608A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651599A1 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1651592A2 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 05/03/2006 | EP1651214A2 Benzimidazole derivatives as mek inhibitors |
| 05/03/2006 | EP1562902B1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/03/2006 | EP1499611A4 Process for 5- 2(r)- 1(r)- 3,5-bis(trifluoromethyl)phenyl|ethoxy|-3(s)-(4-fluorophenyl)-4-morpholinyl|methyl|-1,2-dihydro-3h-1,2,4-triazol-3-one |
| 05/03/2006 | EP1495007A4 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses |
| 05/03/2006 | EP1351954B1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives |
| 05/03/2006 | EP1248771B1 Method for preparing hydroxypicolinic acid derivatives |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1153017B1 Bicyclic compounds and their use as integrin receptor ligands |
| 05/03/2006 | EP0937069B1 Piperazino derivatives as neurokinin antagonists |
| 05/03/2006 | CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 05/03/2006 | CN1768052A Substituted pyrazole compounds |
| 05/03/2006 | CN1768051A Substituted pyrazoles |
| 05/03/2006 | CN1768040A Isoquinoline-5-sulfonic acid amides as inhibitors of AKT (protein kinase B) |
| 05/03/2006 | CN1254474C Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 05/02/2006 | US7038057 Alkylation, acylation |
| 05/02/2006 | US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037916 Antiinflammatory agents; antiarthritic agents; anticholesterol agents; cardiovascular disorders; muscle and skin disorders |
| 05/02/2006 | US7037914 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 05/02/2006 | US7037908 HIV integrase inhibitors |
| 05/02/2006 | US7037880 Ethylene derivatives and pesticides containing said derivatives |
| 04/27/2006 | WO2006044955A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | WO2006044825A2 Mitotic kinesin inhibitors and methods of use thereof |
| 04/27/2006 | WO2006044732A2 2, 6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
| 04/27/2006 | WO2006044682A1 Compounds for nonsense suppression, and methods for their use |
| 04/27/2006 | WO2006044617A1 Oxadiazole ketone inhibitors of fatty acid amide hydrolase |
| 04/27/2006 | WO2006044602A2 Diphenyl substituted alkanes as flap inhiibitors |
| 04/27/2006 | WO2006044457A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 04/27/2006 | WO2006044405A1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | WO2006044228A1 Histamine h3 receptor inhibitors, preparation and therapeutic uses |
| 04/27/2006 | WO2006044133A1 Active ketone inhibitors of tryptase |
| 04/27/2006 | WO2006044000A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | WO2006043539A1 Light-emitting compound, light-emitting polymer compound and light-emitting device |
| 04/27/2006 | WO2006042634A1 4-aminophenyl morpholinone derivatives for the treatment of hepatitis c |
| 04/27/2006 | WO2006042478A1 Small-molecule inhibitors of coronaviral main protease, their preparation and use |
| 04/27/2006 | WO2006000371A3 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 04/27/2006 | WO2005101989A3 Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089369 pyrimidine and pyridine derivatives; diabetes, neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency, cancer |
| 04/27/2006 | US20060089366 New piperazine and piperidine compounds |
| 04/27/2006 | US20060089365 Heterocyclic compounds useful as nurr-1 activators |
| 04/27/2006 | US20060089364 Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents |
| 04/27/2006 | US20060089363 Antibacterial agents |
| 04/27/2006 | US20060089357 Novel compounds and compositions as cathepsin inhibitors |
| 04/27/2006 | US20060089356 Substituted imidazoles as cannabinoid receptor modulators |
| 04/27/2006 | US20060089354 ligands for receptor localization studies; for inhibiting binding of vanilloid ligand to a capsaicin receptor; Phosphoric acid dibenzyl ester 4-(4-tert-butyl-phenylamino)-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-2-ylmethyl ester; to treat neuropathic pain, itch, urinary incontinence, cough, obesity |
| 04/27/2006 | US20060089353 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | US20060089344 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; preventing or treating a pathology in which endogenous cannabinoids and/or any other substrate metabolized by the enzyme FA; analgesics |
| 04/27/2006 | US20060089262 Substituted (thioxo)carbonylamino phenyl uraciles |
| 04/27/2006 | US20060088933 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay |
| 04/27/2006 | DE102004051277A1 Heterocyclische Carbonylverbindungen Heterocyclic carbonyl |
| 04/27/2006 | DE102004050283A1 4-Aminophenyl-morpholinon-Derivate und deren Herstellung 4-aminophenyl-morpholinone derivatives and their preparation |
| 04/27/2006 | CA2584866A1 Mitotic kinesin inhibitors and methods of use thereof |
| 04/27/2006 | CA2584328A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2584262A1 Diphenyl substituted alkanes as flap inhiibitors |
| 04/27/2006 | CA2583710A1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583667A1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583177A1 Compounds for nonsense suppression, and methods for their use |
| 04/27/2006 | CA2580913A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 04/26/2006 | EP1650203A1 Process of preparation of benzimidazol-2-yl quinolinone derivatives |
| 04/26/2006 | EP1650192A1 Quinolone derivative or salt thereof |
| 04/26/2006 | EP1648921A2 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
| 04/26/2006 | EP1648898A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 04/26/2006 | EP1648886A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments |
| 04/26/2006 | EP1648879A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 04/26/2006 | EP1648876A1 5-ht sb 2b /sb receptor antagonists |
| 04/26/2006 | EP1648871A1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 04/26/2006 | EP1648457A2 Piperidine derivatives as melanocortin-4 receptor agonists |
| 04/26/2006 | EP1648448A1 Chemical compounds |
| 04/26/2006 | EP1648447A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 04/26/2006 | EP1648426A2 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 04/26/2006 | EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 04/26/2006 | EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 04/26/2006 | EP1309592B1 Substituted pyrazoles |
| 04/26/2006 | EP1153922B1 Heterodiazinone derivatives |
| 04/26/2006 | CN1764708A Electron transport agents for organic electronic devices |
| 04/26/2006 | CN1764660A Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764651A Quinazoline derivatives as antitumor agents |
| 04/26/2006 | CN1764650A 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 04/26/2006 | CN1764645A Oxamide derivatives useful as raf-kinase inhibitors. |
| 04/26/2006 | CN1764641A Viral polymerase inhibitors |
| 04/26/2006 | CN1764380A N-phenyl- (4-pyridyl)- azinyl!amine derivatives as plant protection agents. |
| 04/26/2006 | CN1763035A Oligothiophene-arylene derivatives and organic thin film transistors using the same |
| 04/26/2006 | CN1763018A Oxazolidinone analog compound |
| 04/26/2006 | CN1763002A Small molecular inhibiting agent for coronavirus main proteinase, its preparation method and uses |